Ren S, Chen J, Xu X, Jiang T, et al. Camrelizumab plus carboplatin and paclitaxel as first-line treatment for advanced squamous non-small-cell lung cancer (CameL-sq): a phase 3 trial. J Thorac Oncol 2021 Dec 16. pii: S1556-0864(21)03392.
PMID: 34923163